Clinical trial
Neuropathic Pain Assessment Comparing Pregabalin and Paroxetine in Management of…
NCT00291148 · University of Manitoba, Other · Completed
Key facts
| NCT number | NCT00291148 |
|---|---|
| Title | Neuropathic Pain Assessment Comparing Pregabalin and Paroxetine in Management of MS-induced Neuropathic Pain |
| Official title | A Comparative Single Center, Randomized Neuropathic Pain Assessment Study Involving Patients With Clinically Definite Multiple Sclerosis (MS) Receiving Treatment With Either Pregabalin or Paroxetine |
| Lead sponsor | University of Manitoba, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Neuropathic Pain, Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | paroxetine, pregabalin |
| Enrollment | 75 |
| Start date | Mar 1, 2006 |
| Primary completion | Jul 1, 2012 |
| Completion | Jul 1, 2012 |
| First posted | Feb 13, 2006 |
| Last update posted | Jul 27, 2012 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: